Report Code : CVMI120520251 | Published Date : May 12, 2025

The global veterinary regenerative medicine market is projected to grow from USD 1.2 billion in 2025 to USD 3.8 billion by 2031, at a 21.4% CAGR, driven by advanced stem cell therapies and exosome technologies.

 

Market Segmentation

By Product Type

    • Stem Cell Therapy (45% shared:
      • Allogeneic adipose-derived MSCs for canine osteoarthritis (Ardent Cell's CaniCell®)
      • Autologous bone marrow concentrates for equine tendon injuries
    • Platelet-Rich Plasma (PRP) (XX%):
      • Next-gen leukocyte-rich formulations show 40% better efficacy
    • Exosome Therapy (Fastest-growing at 28% CAGR):
      • MSC-derived exosomes for feline chronic kidney disease

 

By Application

    • Orthopedics (55% revenue):
      • 75% of sport horse injuries now treated with biologics
    • Dermatology (XX%):
      • Stem cell-conditioned media for atopic dermatitis
    • Organ Repair (Emerging):
      • Liver regeneration in canine hepatopathy

 

By Animal Type

    • Companion Animals (70% market share)
    • Equine (XX%)
    • Livestock (XX% but growing)

 

​​​​​​2. Key Growth Drivers

1. Clinical Efficacy Breakthroughs

  • Canine OA Treatment:
    • Ardent's CaniCell® enhances mobility in 82% of cases (vs 35% with NSAIDs)
  • Equine Tendon Repair:
    • VetStem's therapy reduces re-injury rates from 60% to 18%

 

2. Manufacturing Innovations

  • 3D Bioprinting:
    • Collagen scaffolds with stem cells for cartilage defects
  • Exosome Scalability:
    • Gallant's bioreactors produce 100L/week of MSC exosomes

 

3. Regulatory Advancements

  • FDA's 2025 VSTA Amendments:
    • Expedited pathway for regenerative products
  • EU's ATMP Classification:
    • Standardizes veterinary cell therapies

 

3. Competitive Landscape

Company

Breakthrough

Market Impact

VetStem

Equine tendon MSC therapy

60% US market share

Gallant

Canine exosome platform

$85M Series C funding

Ardent Cell

Off-the-shelf CaniCell®

500+ clinic network

 

4. Future Outlook (2026-2031)

  • 2027: First FDA-approved allogeneic stem cell product
  • 2029: 3D-bioprinted cartilage for canine hip dysplasia
  • 2031: 40% of orthopedic cases treated with biologics




Reasons To Buy

Image



Scope

Image
  • Boehringer Ingelheim International GmbH
  • Dechra Pharmaceuticals PLC
  • Zoetis Inc
  • VetStem, Inc.
  • Vetherapy
  • Ardent
  • Enso Discoveries

 

Veterinary Regenerative Medicine Market Report

 

  1. 1. Veterinary Regenerative Medicine Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Veterinary Regenerative Medicine Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Veterinary Regenerative Medicine Market Research Report - Preface
    1. 2.1 Veterinary Regenerative Medicine Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Product Type
      2. 2.1.2 By Application
      3. 2.1.3 By Animal Type
      4. 2.1.4 By Region
  3. 3. Veterinary Regenerative Medicine Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Product Type, By Application, By Animal Type, By Country
    3. 3.3. Opportunities – By Product Type, By Application, By Animal Type, By Country
    4. 3.4. Trends – By Product Type, By Application, By Animal Type, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Veterinary Regenerative Medicine Market Research Report – DROTs Impact Analysis
    1. 4. Veterinary Regenerative Medicine Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Veterinary Regenerative Medicine Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Stem Cell Therapy
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 Platelet-Rich Plasma
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Exosome Therapy
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Veterinary Regenerative Medicine Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Orthopedics
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Dermatology
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Organ Repair
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Veterinary Regenerative Medicine Market, By Animal Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Companion Animals
    2. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 7.2 Equine
    7. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 7.3 Livestock
    12. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 8. Veterinary Regenerative Medicine Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.5 Middle East and Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.6 Veterinary Regenerative Medicine Market - Opportunity Analysis Index, By Product Type, By Application, By Animal Type, and Region, 2024 - 2031
  1. 9. North America Veterinary Regenerative Medicine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Stem Cell Therapy
      2. 9.1.2 Platelet-Rich Plasma
      3. 9.1.3 Exosome Therapy
      9.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Orthopedics
      2. 9.2.2 Dermatology
      3. 9.2.3 Organ Repair
      9.3 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Companion Animals
      2. 9.3.2 Equine
      3. 9.3.3 Livestock
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
    2. 9.5 North America Veterinary Regenerative Medicine Market – Opportunity Analysis Index, By Product Type, By Application, By Animal Type, and Country, 2024 - 2031
    3. 9.6 Regional Trends Analysis
    4. 9.7 North America Veterinary Regenerative Medicine Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Veterinary Regenerative Medicine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Stem Cell Therapy
      2. 10.1.2 Platelet-Rich Plasma
      3. 10.1.3 Exosome Therapy
      10.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Orthopedics
      2. 10.2.2 Dermatology
      3. 10.2.3 Organ Repair
      10.3 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Companion Animals
      2. 10.3.2 Equine
      3. 10.3.3 Livestock
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 United Kingdom
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Netherlands and Rest of Europe
    2. 10.5 Europe Veterinary Regenerative Medicine Market – Opportunity Analysis Index, By Product Type, By Application, By Animal Type, and Country, 2024 - 2031
    3. 10.6 Regional Trends Analysis
    4. 10.7 Europe Veterinary Regenerative Medicine Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (United Kingdom)
      3. 10.7.3 Company 3 (United Kingdom)
    11. Asia-Pacific Veterinary Regenerative Medicine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Stem Cell Therapy
      2. 11.1.2 Platelet-Rich Plasma
      3. 11.1.3 Exosome Therapy
      11.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Orthopedics
      2. 11.2.2 Dermatology
      3. 11.2.3 Organ Repair
      11.3 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Companion Animals
      2. 11.3.2 Equine
      3. 11.3.3 Livestock
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 China
      2. 11.4.2 Japan
      3. 11.4.3 India
      4. 11.4.4 South Korea
      5. 11.4.5 Australia & New Zealand
      6. 11.4.6 ASEAN
      7. 11.4.7 Rest of Asia-Pacific
    2. 11.5 Asia-Pacific Veterinary Regenerative Medicine Market – Opportunity Analysis Index, By Product Type, By Application, By Animal Type, and Country, 2024 - 2031
    3. 11.6 Regional Trends Analysis
    4. 11.7 Asia-Pacific Veterinary Regenerative Medicine Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (China)
      2. 11.7.2 Company 2 (Japan)
      3. 11.7.3 Company 3 (Japan)
    12. Latin America Veterinary Regenerative Medicine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Stem Cell Therapy
      2. 12.1.2 Platelet-Rich Plasma
      3. 12.1.3 Exosome Therapy
      12.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Orthopedics
      2. 12.2.2 Dermatology
      3. 12.2.3 Organ Repair
      12.3 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Companion Animals
      2. 12.3.2 Equine
      3. 12.3.3 Livestock
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Peru
      5. 12.4.5 Colombia
      6. 12.4.6 Rest of Latin America
    2. 12.5 Latin America Veterinary Regenerative Medicine Market – Opportunity Analysis Index, By Product Type, By Application, By Animal Type, and Country, 2024 - 2031
    3. 12.6 Regional Trends Analysis
    4. 12.7 Latin America Veterinary Regenerative Medicine Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East and Africa Veterinary Regenerative Medicine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Stem Cell Therapy
      2. 13.1.2 Platelet-Rich Plasma
      3. 13.1.3 Exosome Therapy
      13.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Orthopedics
      2. 13.2.2 Dermatology
      3. 13.2.3 Organ Repair
      13.3 By Animal Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Companion Animals
      2. 13.3.2 Equine
      3. 13.3.3 Livestock
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Saudi Arabia
      2. 13.4.2 UAE
      3. 13.4.3 South Africa
      4. 13.4.4 Egypt
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
    2. 13.5 Middle East and Africa Veterinary Regenerative Medicine Market – Opportunity Analysis Index, By Product Type, By Application, By Animal Type, and Country, 2024 - 2031
    3. 13.6 Regional Trends Analysis
    4. 13.7 Middle East and Africa Veterinary Regenerative Medicine Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Saudi Arabia)
      2. 13.7.2 Company 2 (UAE)
      3. 13.7.3 Company 3 (UAE)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
    2. 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 Boehringer Ingelheim International Gmb
      2. 14.2.2 Dechra Pharmaceuticals PLC
      3. 14.2.3 Zoetis Inc
      4. 14.2.4 VetStem Inc.
      5. 14.2.5 Vetherapy
      6. 14.2.6 Ardent
      7. 14.2.7 Enso Discoveries
  1. 15. Data Collection Method and Research Approach
  1. 16. Principal Presumptions and Acronyms